This Slide: #52 of 100 |
Slide #52. Integra LifeSciences — Covidien Confluent Surgical Product Line
Acquirer:
Integra LifeSciences
Acquiree:
Covidien Confluent Surgical Product Line (COV)
Details:
Covidien (NYSE:COV), a leading global provider of healthcare products, announced today that it has entered into a definitive agreement with Integra LifeSciences Corporation to sell its Confluent Surgical product line. The transaction is expected to close by March 31, 2014, subject to receipt of regulatory approvals.
Open the COV Page at The Online Investor »
|
Open the COV Page at The Online Investor (in a new window) »
Free COV Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Buy (2.60 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |